U.S. flag

An official website of the United States government

NM_000527.5(LDLR):c.1304_1307delinsTGGC (p.Glu435_Val436delinsValAla) AND Cardiovascular phenotype

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Mar 17, 2017
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002380907.2

Allele description [Variation Report for NM_000527.5(LDLR):c.1304_1307delinsTGGC (p.Glu435_Val436delinsValAla)]

NM_000527.5(LDLR):c.1304_1307delinsTGGC (p.Glu435_Val436delinsValAla)

Gene:
LDLR:low density lipoprotein receptor [Gene - OMIM - HGNC]
Variant type:
Indel
Cytogenetic location:
19p13.2
Genomic location:
Preferred name:
NM_000527.5(LDLR):c.1304_1307delinsTGGC (p.Glu435_Val436delinsValAla)
HGVS:
  • NC_000019.10:g.11113395_11113398delinsTGGC
  • NG_009060.1:g.29015_29018delinsTGGC
  • NM_000527.5:c.1304_1307delinsTGGCMANE SELECT
  • NM_001195798.2:c.1304_1307delinsTGGC
  • NM_001195799.2:c.1181_1184delinsTGGC
  • NM_001195800.2:c.800_803delinsTGGC
  • NM_001195803.2:c.923_926delinsTGGC
  • NP_000518.1:p.Glu435_Val436delinsValAla
  • NP_000518.1:p.Glu435_Val436delinsValAla
  • NP_001182727.1:p.Glu435_Val436delinsValAla
  • NP_001182728.1:p.Glu394_Val395delinsValAla
  • NP_001182729.1:p.Glu267_Val268delinsValAla
  • NP_001182732.1:p.Glu308_Val309delinsValAla
  • LRG_274t1:c.1304_1307delAGGTinsTGGC
  • LRG_274:g.29015_29018delinsTGGC
  • LRG_274p1:p.Glu435_Val436delinsValAla
  • NC_000019.9:g.11224071_11224074delinsTGGC
  • NM_000527.4:c.1304_1307delAGGTinsTGGC
Molecular consequence:
  • NM_000527.5:c.1304_1307delinsTGGC - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001195798.2:c.1304_1307delinsTGGC - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001195799.2:c.1181_1184delinsTGGC - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001195800.2:c.800_803delinsTGGC - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001195803.2:c.923_926delinsTGGC - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Cardiovascular phenotype
Identifiers:
MedGen: CN230736

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002689870Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Likely pathogenic
(Mar 17, 2017)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Molecular basis of autosomal dominant hypercholesterolemia: assessment in a large cohort of hypercholesterolemic children.

van der Graaf A, Avis HJ, Kusters DM, Vissers MN, Hutten BA, Defesche JC, Huijgen R, Fouchier SW, Wijburg FA, Kastelein JJ, Wiegman A.

Circulation. 2011 Mar 22;123(11):1167-73. doi: 10.1161/CIRCULATIONAHA.110.979450. Epub 2011 Mar 7.

PubMed [citation]
PMID:
21382890

The distribution and characteristics of LDL receptor mutations in China: A systematic review.

Jiang L, Sun LY, Dai YF, Yang SW, Zhang F, Wang LY.

Sci Rep. 2015 Nov 26;5:17272. doi: 10.1038/srep17272. Review.

PubMed [citation]
PMID:
26608663
PMCID:
PMC4660303
See all PubMed Citations (3)

Details of each submission

From Ambry Genetics, SCV002689870.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

The c.1304_1307delAGGTinsTGGC variant (also known as p.E435_V436delinsVA), located in coding exon 9 of the LDLR gene, results from an in-frame deletion of AGGT and insertion of TGGC at nuclelotide positions 1304 to 1307. This results in the deletion of glutamic acid and valine residues and the insertion of valine and alanine residues at codons 435 and 436, respectively. Missense alterations at both of these codons have been reported in association with familial hypercholesterolemia (FH); additionally, one (p.V436A, c.1307T>C) has been shown to co-segregate with disease and reported to result in deficient LDL-receptor expression (Lombardi P et al. Clin. Genet., 1997 Apr;51:286-7; Selberg O et al. J Appl Res., 2003;3:495-504; van der Graaf A et al. Circulation, 2011 Mar;123:1167-73; Jiang L et al. Sci Rep, 2015 Nov;5:17272). These amino acid positions are not well conserved in available vertebrate species. Based on the majority of available evidence to date, this variant is likely to be pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 1, 2024